- Home
- CC vs FOLD Comparison
CC vs FOLD Comparison
Compare CC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- FOLD
- Stock Information
- Founded
- CC 2014
- FOLD 2002
- Country
- CC United States
- FOLD United States
- Employees
- CC N/A
- FOLD N/A
- Industry
- CC Major Chemicals
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- CC Industrials
- FOLD Health Care
- Exchange
- CC Nasdaq
- FOLD Nasdaq
- Market Cap
- CC 2.3B
- FOLD 2.5B
- IPO Year
- CC N/A
- FOLD 2007
- Fundamental
- Price
- CC $13.85
- FOLD $8.86
- Analyst Decision
- CC Buy
- FOLD Strong Buy
- Analyst Count
- CC 8
- FOLD 8
- Target Price
- CC $18.00
- FOLD $27.88
- AVG Volume (30 Days)
- CC 2.8M
- FOLD 5.1M
- Earning Date
- CC 11-06-2025
- FOLD 11-04-2025
- Dividend Yield
- CC 2.53%
- FOLD N/A
- EPS Growth
- CC N/A
- FOLD N/A
- EPS
- CC N/A
- FOLD N/A
- Revenue
- CC $5,850,000,000.00
- FOLD $571,160,000.00
- Revenue This Year
- CC $4.88
- FOLD $21.12
- Revenue Next Year
- CC $0.21
- FOLD $21.23
- P/E Ratio
- CC N/A
- FOLD N/A
- Revenue Growth
- CC 0.62
- FOLD 25.35
- 52 Week Low
- CC $9.13
- FOLD $5.51
- 52 Week High
- CC $22.38
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- CC 44.69
- FOLD 63.71
- Support Level
- CC $12.69
- FOLD $8.33
- Resistance Level
- CC $14.27
- FOLD $8.62
- Average True Range (ATR)
- CC 0.74
- FOLD 0.30
- MACD
- CC 0.02
- FOLD 0.04
- Stochastic Oscillator
- CC 52.68
- FOLD 81.82
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.